D3 receptor antagonists (NeuroSearch)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameD3 receptor antagonists (NeuroSearch)
Drug Alias NameCAM-17
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsDopamine D3 receptor antagonistsSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 1a (5-HT1a) receptorDopamine D3 receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurosearch As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurosearch As
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A